# Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/further-testing-of-donations-that-are-reactive-on-a-licensed-donor-screening-test-for-antibodies-to-hepatitis-c-virus-guidance-for-industry/0893a4f8-36e8-43c7-87c6-14868c8cfa7a

> FDA guidance document: Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus:  Guidance for Industry. Issue date: October 02, 2019. Get complete insights and analysis.

---

## Details

- Title: Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2019-10-02
- Comment Close Date: 2018-12-24
- Last Changed: 2020-07-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-3197">FDA-2018-D-3197</a>

## Related Documents

- [Considerations for the Development of Dried Plasma Products Intended for Transfusion:   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-the-development-of-dried-plasma-products-intended-for-transfusion-guidance-for-industry/c0c693ab-7392-4bad-b4c9-de122a24ced4)
- [Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-assessment-of-blood-donor-eligibility-donor-deferral-and-blood-product-management-in-response-to-ebola-virus-guidance-for-industry/238a4406-3c0e-4cf7-afdd-0a11ad92aeb9)
- [Human Gene Therapy for Hemophilia:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-hemophilia-guidance-for-industry/bceafce9-c9f0-4137-9ca5-071464212a06)